The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Cell And Gene Therapy Contract Research Organization Market Be By 2030 Compared To Its 2026 Market Size?
The cell and gene therapy contract research organization market has experienced significant expansion in recent years. This market is projected to grow from $6.92 billion in 2025 to $7.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.1%. Historically, this growth has been driven by an increasing number of early-stage cell and gene therapy programs, limited internal development capabilities, the expansion of rare disease research pipelines, escalating regulatory complexity in advanced therapies, and a rising dependence on external research expertise.
The cell and gene therapy contract research organization market size is anticipated to undergo substantial growth in the upcoming period. This market is set to reach $12.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This forecasted growth is primarily fueled by a rise in clinical trial engagement for gene therapies, the broadening scope of personalized medicine development, increasing capital allocation towards oncology and genetic disorder studies, a heightened need for quicker development schedules, and more frequent partnerships between biotechnology companies and Contract Research Organizations. Prominent trends anticipated in the forecast period are a greater reliance on external providers for cell and gene therapy investigations, an escalating requirement for comprehensive preclinical and clinical service offerings, an intensified emphasis on regulatory and compliance knowledge, the broadening provision of vector development and production assistance, and the improved application of data-informed trial oversight.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33057&type=smp
What Key Factors Are Shaping The Cell And Gene Therapy Contract Research Organization Market Landscape?
The increasing emphasis on personalized medicine and targeted treatments is anticipated to drive the expansion of the cell and gene therapy contract research organization (CRO) market in the future. Personalized medicine and targeted therapeutics encompass creating treatments specifically designed for unique genetic, molecular, or cellular profiles, aiming to enhance effectiveness and minimize side effects. The attention on personalized medicine is growing because regulators and healthcare systems are increasingly prioritizing therapies based on precision to tackle intricate diseases and attain improved clinical outcomes. Cell and gene therapy contract research organizations (CROs) assist personalized medicine through offering expert preclinical, clinical, and regulatory services essential for the development, testing, and validation of intricate gene- and cell-based therapeutic products. As an illustration, in April 2025, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the Food and Drug Administration (FDA) approved 18 personalized medicines in 2024, which represented roughly 38% of all newly approved therapeutic molecular entities. Consequently, the growing emphasis on personalized medicine and targeted therapeutics is stimulating the expansion of the cell and gene therapy contract research organization (CRO) market.
Which Segment Categories Are Included In The Cell And Gene Therapy Contract Research Organization Market Segment Analysis?
The cell and gene therapy contract research organization market covered in this report is segmented –
1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types
2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services
3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications
4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies
5) By Application: Hospital; Research Institute; Other Applications
Subsegments:
1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services
2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services
3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services
What Market Trends Are Affecting The Cell And Gene Therapy Contract Research Organization Market?
Companies active within the cell and gene therapy contract research organization (CRO) market are concentrating on creating novel solutions, including expanded laboratory and analytical services. Their aim is to improve therapy development efficiency, regulatory compliance, and research precision through the provision of advanced facilities, specialized equipment, and comprehensive cell and gene therapy testing functionalities. These expanded laboratory and analytical services signify contract research organization (CRO) provisions designed to boost capacity, facilitate intricate assay execution, and assist sponsors throughout the entire development process for advanced cell and gene therapies. As an illustration, in August 2025, Labcorp Holdings Inc., a US-based healthcare firm, enlarged its cell and gene therapy laboratory situated in madison, wisconsin. This expansion bolstered its abilities in cell characterization, vector analytics, and testing that adheres to regulations. This enlarged facility offers specialized infrastructure tailored for complex cell and gene therapy workflows, supports high-throughput sample processing, and integrates sophisticated analytical platforms, establishing it as a complete solution for expediting cell and gene therapy research and development.
Who Are The Active Companies Shaping The Cell And Gene Therapy Contract Research Organization Market?
Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC
Get The Full Cell And Gene Therapy Contract Research Organization Market Report:
Which Geographic Region Dominates The Cell And Gene Therapy Contract Research Organization Market?
North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell And Gene Therapy Contract Research Organization Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33057&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Research Organization Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model